Literature DB >> 26823784

Expression of tumoral FOXP3 in gastric adenocarcinoma is associated with favorable clinicopathological variables and related with Hippo pathway.

Jung-Ho Suh1, Kyu Yeoun Won2, Gou Young Kim2, Go Eun Bae2, Sung-Jig Lim2, Ji-Youn Sung3, Yong-Koo Park3, Youn Wha Kim3, Juhie Lee3.   

Abstract

FOXP3 is a transcription factor and well-known hallmark of immune suppressive T regulatory cells (Tregs). Recent studies indicate that, in addition to its association with Treg function in the immune system, FOXP3 plays an important role in tumor development. And important tumor suppressor relay between the FOXP3 and Hippo pathways was found in human cancer. Thus, we investigated tumoral FOXP3, infiltrated Tregs count, Lats2, and YAP expression in gastric adenocarcinoma, and the relationships between expression of these three proteins and p53, Ki67, and other clinicopathological variables. We used 118 gastric adenocarcinoma tissues via immunohistochemical analysis, using a tissue microarray, in relation to survival and other clinicopathological factors. We report the several novel observations about the relationship between tumoral FOXP3 and Hippo pathway components in gastric adenocarcinoma. Positive tumoral FOXP3 expression was significantly related with smaller tumor size, tubular tumor type, lower histological grade, lower T stage, lower recurrence rate, less lymphatic invasion, and less neural invasion. Furthermore, patients with positive tumoral FOXP3 experienced significantly better disease-free and overall survival compared to patients with negative tumoral FOXP3. These findings show that tumoral FOXP3 expression is associated with favorable clinicopathological variables in gastric adenocarcinoma. And we report the novel observation of a relationship between tumoral FOXP3 and Hippo pathway components in gastric adenocarcinoma. Tumoral FOXP3 expression, infiltrated Tregs count, and Lats2 expression were all positively correlated with YAP expression. These findings suggest that the Hippo pathway in gastric adenocarcinoma might be influenced by both tumoral FOXP3 and infiltrated Tregs. In conclusion, the loss of FOXP3 expression in cancer cells is thought to contribute to tumorigenesis and progression of gastric adenocarcinoma. The expression of FOXP3 in gastric adenocarcinoma is related with Lats2 and YAP expression of the Hippo pathway.

Entities:  

Keywords:  FOXP3; Gastric adenocarcinoma; Lats2; YAP

Mesh:

Substances:

Year:  2015        PMID: 26823784      PMCID: PMC4713570     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  36 in total

1.  Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.

Authors:  Katsuhiko Shimizu; Masao Nakata; Yuji Hirami; Takuro Yukawa; Ai Maeda; Kazuo Tanemoto
Journal:  J Thorac Oncol       Date:  2010-05       Impact factor: 15.609

2.  FOXP3 expression and clinical characteristics of hepatocellular carcinoma.

Authors:  Wei-Hua Wang; Chang-Li Jiang; Wei Yan; Yu-Hai Zhang; Jiang-Tao Yang; Cun Zhang; Bo Yan; Wei Zhang; Wei Han; Jun-Zhi Wang; Ying-Qi Zhang
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

3.  Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target.

Authors:  Sandra D Bohling; Kimberly H Allison
Journal:  Mod Pathol       Date:  2008-09-26       Impact factor: 7.842

4.  Foxp3 expression in p53-dependent DNA damage responses.

Authors:  Da-Jung Jung; Dong-Hoon Jin; Seung-Woo Hong; Jee-Eun Kim; Jae-Sik Shin; Daejin Kim; Byung-Joo Cho; Young-Il Hwang; Jae-Seung Kang; Wang-Jae Lee
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

5.  FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.

Authors:  Tao Zuo; Runhua Liu; Huiming Zhang; Xing Chang; Yan Liu; Lizhong Wang; Pan Zheng; Yang Liu
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  Yes-associated protein (YAP) functions as a tumor suppressor in breast.

Authors:  M Yuan; V Tomlinson; R Lara; D Holliday; C Chelala; T Harada; R Gangeswaran; C Manson-Bishop; P Smith; S A Danovi; O Pardo; T Crook; C A Mein; N R Lemoine; L J Jones; S Basu
Journal:  Cell Death Differ       Date:  2008-07-11       Impact factor: 15.828

7.  The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

Authors:  Lisa M Ebert; Bee Shin Tan; Judy Browning; Suzanne Svobodova; Sarah E Russell; Naomi Kirkpatrick; Craig Gedye; Denis Moss; Sweet Ping Ng; Duncan MacGregor; Ian D Davis; Jonathan Cebon; Weisan Chen
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

8.  Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.

Authors:  Tomoki Ito; Shino Hanabuchi; Yi-Hong Wang; Woong Ryeon Park; Kazuhiko Arima; Laura Bover; F Xiao-Feng Qin; Michel Gilliet; Yong-Jun Liu
Journal:  Immunity       Date:  2008-05-29       Impact factor: 31.745

9.  Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate.

Authors:  Lizhong Wang; Runhua Liu; Weiquan Li; Chong Chen; Hiroto Katoh; Guo-Yun Chen; Beth McNally; Lin Lin; Penghui Zhou; Tao Zuo; Kathleen A Cooney; Yang Liu; Pan Zheng
Journal:  Cancer Cell       Date:  2009-10-06       Impact factor: 31.743

10.  FOXP3 expression and overall survival in breast cancer.

Authors:  Andrea Merlo; Patrizia Casalini; Maria Luisa Carcangiu; Chiara Malventano; Tiziana Triulzi; Sylvie Mènard; Elda Tagliabue; Andrea Balsari
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

View more
  13 in total

1.  HDAC6/FOXP3/HNF4α axis promotes bile acids induced gastric intestinal metaplasia.

Authors:  Luyao Zhang; Na Wang; Min Chen; Siran Wu; Jiaoxia Zeng; Fenli Zhou; Qiong Wu; Junye Liu; Yongquan Shi
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

Review 2.  A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy.

Authors:  Masahiro Shibata; Kendall Ham; Mohammad Obaidul Hoque
Journal:  Int J Cancer       Date:  2018-07-24       Impact factor: 7.396

3.  Prognosis genes in gastric adenocarcinoma identified by cross talk genes in disease‑related pathways.

Authors:  Lizhi Zhao; Haichun Lei; Li Shen; Jiquan Tang; Zhiwei Wang; Weisong Bai; Feng Zhang; Shouli Wang; Weihua Li
Journal:  Mol Med Rep       Date:  2017-06-06       Impact factor: 2.952

4.  FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.

Authors:  Shucai Yang; Yi Liu; Ming-Yue Li; Calvin S H Ng; Sheng-Li Yang; Shanshan Wang; Chang Zou; Yujuan Dong; Jing Du; Xiang Long; Li-Zhong Liu; Innes Y P Wan; Tony Mok; Malcolm J Underwood; George G Chen
Journal:  Mol Cancer       Date:  2017-07-17       Impact factor: 27.401

5.  Quantitative proteomic Analysis Reveals up-regulation of caveolin-1 in FOXP3-overexpressed human gastric cancer cells.

Authors:  Duyi Pan; Jing Gao; Xiaoqing Zeng; Guifen Ma; Na Li; Xiaoquan Huang; Xuanling Du; Qing Miao; Jingjing Lian; Lili Xu; Hu Zhou; Shiyao Chen
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

6.  FOXP3 promotes colorectal carcinoma liver metastases by evaluating MMP9 expression via regulating S-adenosylmethionine metabolism.

Authors:  Zhe Wang; Jingdong Zhang
Journal:  Ann Transl Med       Date:  2020-05

7.  Yes-Associated Protein 1 as a Novel Prognostic Biomarker for Gastrointestinal Cancer: A Meta-Analysis.

Authors:  Luo Zhang; Xing Song; Xiaodong Li; Changping Wu; Jingting Jiang
Journal:  Biomed Res Int       Date:  2018-11-14       Impact factor: 3.411

Review 8.  [Emerging roles of Hippo signaling pathway in gastrointestinal cancers and its molecular mechanisms].

Authors:  Yaoping Huang; Feng Yang; Tianhua Zhou; Shanshan Xie
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

9.  Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis.

Authors:  Wen Jiang; Ke Liu; Qing Guo; Ji Cheng; Liming Shen; Yinghao Cao; Jing Wu; Jianguo Shi; Heng Cao; Bo Liu; Kaixiong Tao; Guobin Wang; Kailin Cai
Journal:  Oncotarget       Date:  2017-05-03

10.  Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma.

Authors:  Alberto D'Angelo; Navid Sobhani; Giandomenico Roviello; Stefan Bagby; Deborah Bonazza; Cristina Bottin; Fabiola Giudici; Fabrizio Zanconati; Nicolo De Manzini; Alessandra Guglielmi; Daniele Generali
Journal:  PLoS One       Date:  2019-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.